Is pyridoxine helpful in preventing palmar-plantar erythrodysesthesia associated with capecitabine?
Jeung
Hei Cheul
HC
Chung
Hyun Cheol
HC
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000069287:Capecitabine; D002986:Clinical Trials as Topic; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D004890:Erythema / Q000139:chemically induced / Q000517:prevention & control*; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D005528:Foot / Q000473:pathology; D006225:Hand / Q000473:pathology; D006801:Humans; D011736:Pyridoxine / Q000627:therapeutic use*; D013577:Syndrome; D014803:Vitamin B Complex / Q000627:therapeutic use*
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D014803:Vitamin B Complex; D000069287:Capecitabine; D011736:Pyridoxine; D005472:Fluorouracil